Changing prostaglandin E2 (PGE2) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE2 receptor EP2 and EP4
Open Access
- 2 December 2021
- journal article
- research article
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 21 (1) , e12426
Abstract
Purpose: We investigated the change, if any, in prostaglandin E2 (PGE2) signaling in endometriotic lesions of different developmental stages in mouse. In addition, we evaluated the effect of treatment of mice with induced deep endometriosis (DE) with inhibitors of PGE2 receptor subtypes EP2 and EP4 and metformin.Methods: Three mouse experimentations were conducted. In Experiment 1, female Balb/C mice were induced with endometriosis or DE and were serially sacrificed after induction. Experiments 2 and 3 evaluated the effect of treatment with EP2 and EP4 inhibitors and metformin, respectively, in mice with induced DE. Immunohistochemistry analysis of COX‐2, EP2, and EP4, along with the extent of lesional fibrosis, was evaluated.Results: The immunostaining of COX‐2, EP2, and EP4 turned from activation to a stall as lesions progressed. Treatment with EP2/EP4 inhibitors in DE mice exacerbated endometriosis‐associated hyperalgesia and promoted fibrogenesis in lesions even though it suppressed the PGE2 signaling dose‐dependently. In contrast, treatment with metformin resulted in increased PGE2 signaling, concomitant with improved hyperalgesia, and retarded lesional fibrogenesis.Conclusions: The PGE2 signaling diminishes as endometriotic lesions progress. Treatment with EP2/EP4 inhibitors in DE mice exacerbates endometriosis, but metformin appears to be promising seemingly through the induction of the PGE2 signaling.Keywords
Funding Information
- Science and Technology Commission of Shanghai Municipality (2017ZZ01016)
- National Natural Science Foundation of China (81771553, 81871144, 82071623)
- Shanghai Municipal Hospital Development Center (SHDC2020CR2062B)
This publication has 99 references indexed in Scilit:
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms1Biology of Reproduction, 2013
- Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic SteatohepatitisPLOS ONE, 2012
- In vitroandin vivocharacterization of PF‐04418948, a novel, potent and selective prostaglandin EP2receptor antagonistBritish Journal of Pharmacology, 2011
- Feedback amplification of fibrosis through matrix stiffening and COX-2 suppressionJournal of Cell Biology, 2010
- Selective blockade of prostaglandin E2 receptors EP2 and EP4 signaling inhibits proliferation of human endometriotic epithelial cells and stromal cells through distinct cell cycle arrestFertility and Sterility, 2010
- Prostaglandin E 2 induces fibroblast apoptosis by modulating multiple survival pathwaysThe FASEB Journal, 2009
- Up-Regulation of Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Endometriotic Cells by Macrophage Migration Inhibitory Factor: Involvement of Novel Kinase Signaling PathwaysEndocrinology, 2009
- AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolismCell Metabolism, 2005
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Use of knockout transgenic mice in the study of endometriosis: insights from mice lacking β2-microglobulin and interleukin-12p40Fertility and Sterility, 2001